|Project Title||Absence of Venous Thromboembolism Risk Following Quadrivalent Human Papillomavirus Vaccination, Vaccine Safety Datalink, 2008–2011|
Saturday, January 2, 2016
To investigate concerns about a potential association between quadrivalent human papillomavirus vaccination (HPV4) and venous thromboembolism (VTE), a self-controlled case series study was conducted in adolescents and young adults 9–26 years of age in the Vaccine Safety Datalink.
quadrivalent human papillomavirus vaccination (HPV4)
venous thromboembolism (VTE)